Mendes, R.E., Sader, H.S., Deshpande, L.M., Diep, B.A., Chambers, H.F. and Jones, R.N. (2010) Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid. Journal of Clinical Microbiology, 48, 568-574.
http://dx.doi.org/10.1128/JCM.01384-09

has been cited by the following article:

• TITLE: Methicillin-Resistant Staphylococcus aureus SCCmec Type and Its Association with Clinical Presentation, Severity, and Length of Stay among Patients with Complicated Skin and Skin Structure Infections

  AUTHORS: Eric Gomez, Tom Chiang, Patricia A. Hogan, Daniela E. Myers, David B. Huang

  KEYWORDS: MRSA, SCCmec Type, Infection Severity, Length of Stay

  JOURNAL NAME: Advances in Infectious Diseases, Vol.4 No.2, June 13, 2014

  ABSTRACT: Data from a prospective, randomized, open-label, active-controlled, multicenter, Phase 4 study comparing oral or intravenous linezolid with intravenous vancomycin for treatment of complicated skin and soft-tissue infections caused by methicillin resistant Staphylococcus aureus was used to determine the association between staphylococcal cassette chromosome mec (SCCmec) type and patient’s clinical presentation, infection severity, intravenous therapy duration and length of stay (LOS). Compared to SCCmec types I, II, and III, SCCmec type IV, PVL+ was associated with more frequent presentation of abscesses, lower severity scores, and shorter intravenous therapy duration and LOS in both treatment groups.